announcement out-investor presentation, page-11

Do you think that they have been snorting at my prognosis ...

An estimation–use and abuse as you please


World population 6 740 000 000

China/India (2 400 000 000) to provide 30 % support = 720 000 000 treatments

Euro/America’s (1 500 000 000) to provide 70% support = 1 050 000 000 treatments

SE Asia (1 400 000 000) to provide 30% support = 420 000 000 treatments

Africa (900 000 000) to provide 10% support = 90 000 000 treatments

Not withstanding World Health Group’s and other appeals

Total population that can have sustainable treatment = 2 285 000 000

Production/Stockpile (possible scenario) available treatment (25% of sustainable treatment) = 571 250 000 treatments

Relenza component = 35% (my conservative approach considering WHO recommendations) = 199 937 500
Multiplied by $15/packet (very rough figure) = 2 999 062 500

Multiplied by 7% royalties = 209 934 375

Divided by 180 000 000 shares available = 1.166

Consider greater than 25% availability as a mid term likely; consider greater participation in Asia’s, and particularly Africa. World health participation would be prominent. … Short to mid term forecasts could see sums pop toward 3.50 or if not paranoid; except 100% … 4.50

Then, hopefully LANI will be effective. … 7.80 ish


Thoughts that will become fallacies … good health